Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study-Reference-Cited by-同舟云学术

Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study

Published:2024-06 Issue:6 Volume:24 Page:629-638
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Brito Marcelo,Rufatto Rosilene,Brito-Sousa José Diego,Murta Felipe,Sampaio Vanderson,Balieiro Patrícia,Baía-Silva Djane,Castro Vanessa,Alves Brenda,Alencar Aline,Duparc Stephan,Grewal Daumerie Penny,Borghini-Fuhrer Isabelle,Jambert Elodie,Peterka Cássio,Edilson Lima Francisco,Carvalho Maia Leonardo,Lucena Cruz Catherine,Maciele Bruna,Vasconcelos Mariana,Machado Myrna,Augusto Figueira Elder,Alcirley Balieiro Antônio,Batista Pereira Dhelio,Lacerda Marcus

Funder

Bill & Melinda Gates Foundation

Oswaldo Cruz Foundation

Publisher

Elsevier BV

Reference24 articles.

1. Factors associated with non-adherence to the treatment of vivax malaria in a rural community from the Brazilian Amazon Basin;Almeida;Rev Soc Bras Med Trop,2016

2. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon;Grietens;Am J Trop Med Hyg,2010

3. Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria;Lacerda;N Engl J Med,2019

4. Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria;Llanos-Cuentas;N Engl J Med,2019

5. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency;Chu;Malar J,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Malaria Elimination: A Case-Control Study to Assess Associated Factors to Malaria Relapses in the Extra-Amazon Region of Brazil From 2008 to 2019;2024-09-09

2. Investigation of P. vivax elimination via mass drug administration: A simulation study;Epidemics;2024-09

3. Progress towards safer and more effective radical cure of Plasmodium vivax;The Lancet Infectious Diseases;2024-06

4. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria;Malaria Journal;2024-05-13